ArticleBritish journal of haematology2023

Patient-derived xenograft models of ALK+ ALCL reveal preclinical promise for therapy with brigatinib.

Nina Prokoph et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.